Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies. It specializes in the discovery, development, and treatment approaches for autoimmune diseases. The company provides a precision analytics platform with genetic, clinical, and health records data to create medicines.